Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | Immuno-oncology in renal cell carcinoma: new combinations are coming

Hans Hammers, MD, PhD, of the University of Texas Southwestern Medical Center, Texas, USA, discusses the immunotherapeutic landscape for renal cell carcinoma, including upcoming combinations. This interview took place at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.